Read this report that summarises the insights from twenty pharmaceutical industry professionals working in IT and pharmacovigilance departments
Resources
The Essence of GLP Test Item Characterisation: Ensuring Precision in Non-Clinical Studies
Together with our GLP Auditor Michelle Anderson, we delve into the significance of test item characterisation in GLP.
Whitepaper | Analysis of Future Trends and Technologies in Pharmacovigilance
In this Whitepaper, we analyse the current and future changes in the pharmacovigilance field, and how technology plays a critical role.
5 Benefits of Performing a Vulnerability Assessment
As the Life Sciences industry embraces technology, vulnerability assessments and penetration testing are essential tools for securing your critical assets.
On Demand Webinar (Italian language) | I sistemi integrati per la gestione delle attività nel mondo dell’industria biomedicale: il caso VEEVA
Quali sono i benefici dei sistemi integrati, cloud based, per il mondo Life Sciences? Scopri, in questo webinar, le esperienze dirette di alcune importanti realtà farmaceutiche.
A look at Real World Data (RWD) and Real World Evidence (RWE)
A look at RWD and RWE, describing differences and their significant support to medicines evaluation and regulatory decision-making in Life Science.
Mock Inspections: 3 Tips to Proceed in the Right Direction
Investing in a regulatory mock inspection demonstrates a serious commitment to patient safety, data integrity, and regulatory compliance.
Overcoming the Challenges of Cloud Migration in Life Sciences Companies: Solutions and Strategies
Advantages and challenges of Cloud Migration in the Healthcare and Life Sciences industries: solutions and strategies for the future.
How can you change your approach from Computer System Validation to Computer Software Assurance?
A strong Quality Management System allows you to change your approach from Computer System Validation to Computer Software Assurance. How is it possible? Let’s discover together.
How to select your pharmacovigilance partner
The challenge will be to identify potential partners and select one which will fit your pharmacovigilance needs.
